- Home
- RETO vs ENLV Comparison
RETO vs ENLV Comparison
Compare RETO & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RETO
- ENLV
- Stock Information
- Founded
- RETO 1999
- ENLV 2005
- Country
- RETO China
- ENLV Israel
- Employees
- RETO N/A
- ENLV N/A
- Industry
- RETO Multi-Sector Companies
- ENLV Biotechnology: Pharmaceutical Preparations
- Sector
- RETO Consumer Discretionary
- ENLV Health Care
- Exchange
- RETO Nasdaq
- ENLV Nasdaq
- Market Cap
- RETO 24.7M
- ENLV 25.5M
- IPO Year
- RETO 2017
- ENLV 1995
- Fundamental
- Price
- RETO $1.17
- ENLV $1.13
- Analyst Decision
- RETO
- ENLV Strong Buy
- Analyst Count
- RETO 0
- ENLV 2
- Target Price
- RETO N/A
- ENLV $10.00
- AVG Volume (30 Days)
- RETO 242.8K
- ENLV 175.2K
- Earning Date
- RETO 10-27-2025
- ENLV 08-29-2025
- Dividend Yield
- RETO N/A
- ENLV N/A
- EPS Growth
- RETO N/A
- ENLV N/A
- EPS
- RETO N/A
- ENLV N/A
- Revenue
- RETO $1,828,976.00
- ENLV N/A
- Revenue This Year
- RETO N/A
- ENLV N/A
- Revenue Next Year
- RETO N/A
- ENLV N/A
- P/E Ratio
- RETO N/A
- ENLV N/A
- Revenue Growth
- RETO N/A
- ENLV N/A
- 52 Week Low
- RETO $1.10
- ENLV $0.81
- 52 Week High
- RETO $13.80
- ENLV $2.10
- Technical
- Relative Strength Index (RSI)
- RETO 31.05
- ENLV 57.20
- Support Level
- RETO $1.22
- ENLV $1.01
- Resistance Level
- RETO $1.26
- ENLV $1.08
- Average True Range (ATR)
- RETO 0.12
- ENLV 0.04
- MACD
- RETO 0.00
- ENLV 0.02
- Stochastic Oscillator
- RETO 13.11
- ENLV 87.86
About RETO ReTo Eco-Solutions Inc.
ReTo Eco-Solutions Inc is a manufacturer and distributor of eco-friendly construction materials and fly-ash, as well as equipment used to produce these eco-friendly construction materials. The company engaged in providing consultation, design, project implementation and construction of urban ecological environments for capturing, controlling and re-using rainwater. It operates through four segments namely Machinery and Equipment sales, Construction materials sales, Municipal Construction Projects, and Technology Consulting and other services. The company earns its revenue from Machinery and Equipment sales segment. Geographically, it derives a majority of its revenue from China.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.